tripelennamine has been researched along with Stevens-Johnson Syndrome in 1 studies
Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.
Stevens-Johnson Syndrome: Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| CHIPPS, JE | 1 |
1 other study available for tripelennamine and Stevens-Johnson Syndrome
| Article | Year |
|---|---|
Erythema multiforme exudativum (Stevens-Johnson syndrome); a review of a case report in which use of aureomycin and pyribenzamine were without apparent benefit.
Topics: Chlortetracycline; Erythema Multiforme; Humans; Stevens-Johnson Syndrome; Thiouracil; Tripelennamine | 1951 |